GenSight Biologics S.A. (GSGTF)
OTCMKTS · Delayed Price · Currency is USD
0.1901
-0.0499 (-20.79%)
At close: Aug 18, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of $21.46 million as of February 12, 2026. Its market cap has decreased by -45.02% in one year.
Market Cap
21.46M
Enterprise Value
43.70M
Revenue
1.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 279.96M to 21.46M, a decrease of -92.34%. That is a compound annual growth rate of -23.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 20.51M | -24.11% |
| Dec 31, 2025 | 27.03M | -21.02% |
| Dec 31, 2024 | 34.22M | 20.63% |
| Dec 29, 2023 | 28.37M | -82.90% |
| Dec 30, 2022 | 165.86M | -42.89% |
| Dec 31, 2021 | 290.43M | -21.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 31.12M |
| Oncotelic Therapeutics | 27.82M |
| EOM Pharmaceuticals Holdings | 22.63M |
| Finch Therapeutics Group | 22.08M |
| Zenith Capital | 20.77M |
| Provectus Biopharmaceuticals | 18.79M |
| Zeo ScientifiX | 18.66M |